Definitely a binary situation. I'm confident that the DME study will go well. Other VEGF-A drugs work here and are Standard of Care.
Too bad the market are panicky, the valuation / potential buyout would be at higher prices, if that occurs.
If DME successful, Big Pharma will be very interested in a combo treatment.
Sometimes the hardest trade is the one in high anxiety markets, but it creates opportunity. GLTA.
Definitely a binary situation. I'm confident that the DME study...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.0¢ |
Change
0.025(3.03%) |
Mkt cap ! $1.046B | |||
| Open | High | Low | Value | Volume |
| 82.0¢ | 87.0¢ | 81.0¢ | $2.966M | 3.483M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 84.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 980 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |